welcome
CBS News

CBS News

Health

Health

How Trump health agency cuts could impact Alzheimer's research and patients

CBS News
Summary
Nutrition label

85% Informative

The Alzheimer's Association says two related programs have had staff placed on administrative leave.

Federal funding for Alzheimer's research accounts for as much as $3.8 billion each year .

Cuts could threaten "the entire pipeline of early-stage medical innovations that could transform Alzheimer's care," CEO says.

Longeveron 's drug has received NIH funding for a non-Alzheimer's, pediatrics-related trial.

The Alzheimer's Association funded the Phase 1 trial for the drug, Hare said.

He said company remains "full steam ahead" on getting its product to those who "need it as quickly as possible".